▲ +11.07% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for HealthEquity in the last 3 months. The average price target is $82.78, with a high forecast of $92.00 and a low forecast of $70.00. The average price target represents a 11.07% upside from the last price of $74.53.
The current consensus among 10 contributing investment analysts is to buy stock in HealthEquity. This Buy consensus rating has held steady for over two years.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.